德信的投资者关系让股东了解公司进展和计划。
非独立执行主席
非独立非执行董事
资深独立非执行董事
独立非执行董事
独立非执行董事
独立非执行董事
非独立执行主席
了解更多公司的公告
Declares third interim dividend of 0.8 sen for 3QFY26, totalling RM39.78 million
Cyberjaya, 28 January 2026 – DXN Holdings Bhd. (“DXN” or the “Company”) [德信控股], a leading global manufacturer of nutraceutical products, today announced its unaudited results for the third quarter ended 30 November 2025 (“3QFY26”) and nine months financial results for the financial year ending 28 February 2026 (“9MFY26”) for the Company and its subsidiaries.
查看更多EBITDA margin improves to 28.3%; Board declares second interim dividend
宣布派发首个中期股息每股0.9仙,保持良好盈利能力并实现绿色基础设施里程碑。
• 强劲销售表现:收入达到创纪录的19亿令吉(2024财年:18亿令吉)
• 提高股息派发:宣布派发第四次中期股息每股1.0仙,使全年总股息达到每股3.7仙,相当于约7%的股息收益率(2024财年:每股3.6仙)
• 资产负债表稳健:现金及现金等价物达6.722亿令吉,是总贷款和借款1.549亿令吉的四倍以上
~ 加强在快速增长地区的布局,拉丁美洲和亚洲成为主要增长动力 ~
~ 宣布派发第二次中期股息每股0.8仙 ~
~ 宣布派发首次中期股息每股0.9仙 ~
Health
Food and Beverage
Personal Care
Nutrition
Beauty
Branch
Business
Register